Company research / BIVI

Biovie Inc. (BIVI)

Also trades as BIVIW. Every security a company lists rests on one set of financial statements, so these figures cover the whole company.

SEC name BIOVIE INC. · CIK 0001580149 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated NV
  • Fiscal year ends Jun 30

Key ratios (year ended 2026-06-30)

-214.9%
Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form DEF 14A (proxy statement) · 2026-09-28

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Stock splits: 1-for-10, first reflected in a filing dated 2025-08-15. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView